Repertoire Collaborates with Yale University to Identify Novel Antigen and T- Cell Receptor for Multiple Sclerosis
Shots:
- Repertoire and Yale University collaborated to understand the immunological causes of MS by identifying the specificity of various subsets of T cells
- The focus of the agreement is to determine the specificity of T cells obtained from the CSF of patients living with MS and determine the pathogenic T cells driving MS and the antigens that activate them
- Yale will provide human TCR sequences to Repertoire which will deploy its DECODE platform to identify the novel antigens that drive cellular immunity
Ref: Businesswire | Image: Repertoire
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com